Veterinary Viral Vectored Vaccine Market, Global Outlook and Forecast 2022-2028

June 2022 | 71 pages | ID: V8715B7AD71EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Veterinary Viral Vectored Vaccine in global, including the following market information:

Global Veterinary Viral Vectored Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Veterinary Viral Vectored Vaccine Market Sales, 2017-2022, 2023-2028, (Units)

Global top five Veterinary Viral Vectored Vaccine companies in 2021 (%)

The global Veterinary Viral Vectored Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Alphaherpesvirus (HVT) Vector Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Veterinary Viral Vectored Vaccine include Boehringer-Ingelheim and Ceva etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Viral Vectored Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Veterinary Viral Vectored Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Veterinary Viral Vectored Vaccine Market Segment Percentages, by Type, 2021 (%)

• Alphaherpesvirus (HVT) Vector
• Canarypox Vector
• Vaccinia Vector

Global Veterinary Viral Vectored Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Veterinary Viral Vectored Vaccine Market Segment Percentages, by Application, 2021 (%)

• Pet
• Chicken
• Others

Global Veterinary Viral Vectored Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)

Global Veterinary Viral Vectored Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Veterinary Viral Vectored Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Veterinary Viral Vectored Vaccine revenues share in global market, 2021 (%)

Key companies Veterinary Viral Vectored Vaccine sales in global market, 2017-2022 (Estimated), (Units)

Key companies Veterinary Viral Vectored Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Boehringer-Ingelheim
• Ceva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Veterinary Viral Vectored Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Veterinary Viral Vectored Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL VETERINARY VIRAL VECTORED VACCINE OVERALL MARKET SIZE

2.1 Global Veterinary Viral Vectored Vaccine Market Size: 2021 VS 2028
2.2 Global Veterinary Viral Vectored Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Veterinary Viral Vectored Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Veterinary Viral Vectored Vaccine Players in Global Market
3.2 Top Global Veterinary Viral Vectored Vaccine Companies Ranked by Revenue
3.3 Global Veterinary Viral Vectored Vaccine Revenue by Companies
3.4 Global Veterinary Viral Vectored Vaccine Sales by Companies
3.5 Global Veterinary Viral Vectored Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Veterinary Viral Vectored Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Veterinary Viral Vectored Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Viral Vectored Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Veterinary Viral Vectored Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Veterinary Viral Vectored Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Veterinary Viral Vectored Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Alphaherpesvirus (HVT) Vector
  4.1.3 Canarypox Vector
  4.1.4 Vaccinia Vector
4.2 By Type - Global Veterinary Viral Vectored Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Veterinary Viral Vectored Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Veterinary Viral Vectored Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Veterinary Viral Vectored Vaccine Sales & Forecasts
  4.3.1 By Type - Global Veterinary Viral Vectored Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Veterinary Viral Vectored Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Veterinary Viral Vectored Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Veterinary Viral Vectored Vaccine Market Size, 2021 & 2028
  5.1.2 Pet
  5.1.3 Chicken
  5.1.4 Others
5.2 By Application - Global Veterinary Viral Vectored Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Veterinary Viral Vectored Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Veterinary Viral Vectored Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Veterinary Viral Vectored Vaccine Sales & Forecasts
  5.3.1 By Application - Global Veterinary Viral Vectored Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Veterinary Viral Vectored Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Veterinary Viral Vectored Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Veterinary Viral Vectored Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Veterinary Viral Vectored Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Veterinary Viral Vectored Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Veterinary Viral Vectored Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Veterinary Viral Vectored Vaccine Sales & Forecasts
  6.3.1 By Region - Global Veterinary Viral Vectored Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Veterinary Viral Vectored Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Veterinary Viral Vectored Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Veterinary Viral Vectored Vaccine Sales, 2017-2028
  6.4.3 US Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.4.4 Canada Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.4.5 Mexico Veterinary Viral Vectored Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Veterinary Viral Vectored Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Veterinary Viral Vectored Vaccine Sales, 2017-2028
  6.5.3 Germany Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.5.4 France Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.5.5 U.K. Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.5.6 Italy Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.5.7 Russia Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.5.9 Benelux Veterinary Viral Vectored Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Veterinary Viral Vectored Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Veterinary Viral Vectored Vaccine Sales, 2017-2028
  6.6.3 China Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.6.4 Japan Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.6.5 South Korea Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.6.7 India Veterinary Viral Vectored Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Veterinary Viral Vectored Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Veterinary Viral Vectored Vaccine Sales, 2017-2028
  6.7.3 Brazil Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.7.4 Argentina Veterinary Viral Vectored Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales, 2017-2028
  6.8.3 Turkey Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.8.4 Israel Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Veterinary Viral Vectored Vaccine Market Size, 2017-2028
  6.8.6 UAE Veterinary Viral Vectored Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Boehringer-Ingelheim
  7.1.1 Boehringer-Ingelheim Corporate Summary
  7.1.2 Boehringer-Ingelheim Business Overview
  7.1.3 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Major Product Offerings
  7.1.4 Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 Boehringer-Ingelheim Key News
7.2 Ceva
  7.2.1 Ceva Corporate Summary
  7.2.2 Ceva Business Overview
  7.2.3 Ceva Veterinary Viral Vectored Vaccine Major Product Offerings
  7.2.4 Ceva Veterinary Viral Vectored Vaccine Sales and Revenue in Global (2017-2022)
  7.2.5 Ceva Key News

8 GLOBAL VETERINARY VIRAL VECTORED VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Veterinary Viral Vectored Vaccine Production Capacity, 2017-2028
8.2 Veterinary Viral Vectored Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Veterinary Viral Vectored Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 VETERINARY VIRAL VECTORED VACCINE SUPPLY CHAIN ANALYSIS

10.1 Veterinary Viral Vectored Vaccine Industry Value Chain
10.2 Veterinary Viral Vectored Vaccine Upstream Market
10.3 Veterinary Viral Vectored Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Veterinary Viral Vectored Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Veterinary Viral Vectored Vaccine in Global Market
Table 2. Top Veterinary Viral Vectored Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Veterinary Viral Vectored Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Veterinary Viral Vectored Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Veterinary Viral Vectored Vaccine Sales by Companies, (Units), 2017-2022
Table 6. Global Veterinary Viral Vectored Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Veterinary Viral Vectored Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Veterinary Viral Vectored Vaccine Product Type
Table 9. List of Global Tier 1 Veterinary Viral Vectored Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Viral Vectored Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Veterinary Viral Vectored Vaccine Sales (Units), 2017-2022
Table 15. By Type - Global Veterinary Viral Vectored Vaccine Sales (Units), 2023-2028
Table 16. By Application – Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Veterinary Viral Vectored Vaccine Sales (Units), 2017-2022
Table 20. By Application - Global Veterinary Viral Vectored Vaccine Sales (Units), 2023-2028
Table 21. By Region – Global Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Veterinary Viral Vectored Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Veterinary Viral Vectored Vaccine Sales (Units), 2017-2022
Table 25. By Region - Global Veterinary Viral Vectored Vaccine Sales (Units), 2023-2028
Table 26. By Country - North America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Veterinary Viral Vectored Vaccine Sales, (Units), 2017-2022
Table 29. By Country - North America Veterinary Viral Vectored Vaccine Sales, (Units), 2023-2028
Table 30. By Country - Europe Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Veterinary Viral Vectored Vaccine Sales, (Units), 2017-2022
Table 33. By Country - Europe Veterinary Viral Vectored Vaccine Sales, (Units), 2023-2028
Table 34. By Region - Asia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Veterinary Viral Vectored Vaccine Sales, (Units), 2017-2022
Table 37. By Region - Asia Veterinary Viral Vectored Vaccine Sales, (Units), 2023-2028
Table 38. By Country - South America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Veterinary Viral Vectored Vaccine Sales, (Units), 2017-2022
Table 41. By Country - South America Veterinary Viral Vectored Vaccine Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales, (Units), 2023-2028
Table 46. Boehringer-Ingelheim Corporate Summary
Table 47. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Product Offerings
Table 48. Boehringer-Ingelheim Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Ceva Corporate Summary
Table 50. Ceva Veterinary Viral Vectored Vaccine Product Offerings
Table 51. Ceva Veterinary Viral Vectored Vaccine Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Veterinary Viral Vectored Vaccine Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 53. Global Veterinary Viral Vectored Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Veterinary Viral Vectored Vaccine Production by Region, 2017-2022 (Units)
Table 55. Global Veterinary Viral Vectored Vaccine Production by Region, 2023-2028 (Units)
Table 56. Veterinary Viral Vectored Vaccine Market Opportunities & Trends in Global Market
Table 57. Veterinary Viral Vectored Vaccine Market Drivers in Global Market
Table 58. Veterinary Viral Vectored Vaccine Market Restraints in Global Market
Table 59. Veterinary Viral Vectored Vaccine Raw Materials
Table 60. Veterinary Viral Vectored Vaccine Raw Materials Suppliers in Global Market
Table 61. Typical Veterinary Viral Vectored Vaccine Downstream
Table 62. Veterinary Viral Vectored Vaccine Downstream Clients in Global Market
Table 63. Veterinary Viral Vectored Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Veterinary Viral Vectored Vaccine Segment by Type
Figure 2. Veterinary Viral Vectored Vaccine Segment by Application
Figure 3. Global Veterinary Viral Vectored Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Veterinary Viral Vectored Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Veterinary Viral Vectored Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Veterinary Viral Vectored Vaccine Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Veterinary Viral Vectored Vaccine Revenue in 2021
Figure 9. By Type - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Veterinary Viral Vectored Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Veterinary Viral Vectored Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 19. US Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 33. China Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Veterinary Viral Vectored Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Veterinary Viral Vectored Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Veterinary Viral Vectored Vaccine Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Veterinary Viral Vectored Vaccine by Region, 2021 VS 2028
Figure 50. Veterinary Viral Vectored Vaccine Industry Value Chain
Figure 51. Marketing Channels